Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell‐specific extracellular vesicles
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Ashish Kumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carol…. Hauptthemen laut MEDLINE: Alzheimer Disease, Extracellular Vesicles, Proteomics, Brain. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Blood‐based biomarkers are essential for early detection, monitoring, and therapeutic development in Alzheimer's disease (AD) and related dementia (ADRD), but current assays lack brain cell specificity and sensitivity to low‐abundant proteins. METHOD We isolated the following brain cell‐derived small extracellular vesicles (sEV) from the plasma of individuals with normal cognition (CN), mild cognitive impairment (MCI), or ADRD: neurons (NDE), astrocytes (ADE), microglia (MDE), oligodendrocytes (ODE), pericytes (PDE), and endothelial cells (EDE). Using NULISAseq, we profiled 122 proteins, spanning AD pathology, neurodegeneration, and neuroinflammation. RESULTS sEV proteomes showed distinct brain cell‐type‐specific signatures. MCI exhibited early dysregulation of neuroprotective, inflammatory, and vascular markers in NDE, MDE, and ODE. ADRD displayed broader alteration tau, amyloid, neuroinflammation, vascular dysfunction, and synaptic loss across multiple sEV populations. DISCUSSION Combining NULISAseq with brain cell‐derived plasma sEV enables the detection of multicellular molecular changes in ADRD, supporting their use as a minimally invasive platform for biomarker discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
ORCID-Profile: Gagan Deep
Förderung
- NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- NIA NIH HHS
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences
- National Institute on Aging
Zitieren
APA
Kumar, A., Sharma, M., Su, Y., Singh, S., Tanley, J. E., Casanova, R., Hsu, F. C., Craft, S., Mielke, M. M., Hughes, T. M., & Deep, G. (2026). Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell‐specific extracellular vesicles. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71717
Vancouver
Kumar A, Sharma M, Su Y, Singh S, Tanley JE, Casanova R, et al. Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell‐specific extracellular vesicles. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71717
BibTeX
@article{Kumar2026,
author = {Kumar, Ashish and Sharma, Mitu and Su, Yixin and Singh, Sangeeta and Tanley, Jordan E and Casanova, Ramon and Hsu, Fang-Chi and Craft, Suzanne and Mielke, Michelle M and Hughes, Timothy M and Deep, Gagan},
title = {Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell‐specific extracellular vesicles},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71717}
}
EUVIMED